Bamco Inc. NY bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 10,059 shares of the healthcare conglomerate's stock, valued at approximately $4,181,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. PBCay One RSC Ltd purchased a new position in UnitedHealth Group during the first quarter valued at $14,343,000. Lee Johnson Capital Management LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $6,180,000. Vaughan David Investments LLC IL boosted its position in shares of UnitedHealth Group by 2.7% during the 4th quarter. Vaughan David Investments LLC IL now owns 150,773 shares of the healthcare conglomerate's stock valued at $49,772,000 after acquiring an additional 3,934 shares during the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. boosted its holdings in UnitedHealth Group by 1,287.2% in the 1st quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate's stock valued at $16,241,000 after purchasing an additional 55,695 shares during the last quarter. Finally, Kinsale Capital Group Inc. grew its position in UnitedHealth Group by 13.4% in the second quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate's stock worth $16,006,000 after acquiring an additional 4,557 shares during the period. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Stock Down 1.6%
UnitedHealth Group stock opened at $394.57 on Friday. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $354.16 billion, a price-to-earnings ratio of 25.39, a PEG ratio of 1.39 and a beta of 0.62. The stock has a 50 day moving average of $413.42 and a two-hundred day moving average of $359.88. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating analysts' consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same period in the previous year, the business earned $4.08 earnings per share. The company's revenue for the quarter was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be issued a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.4%. The ex-dividend date is Monday, September 14th. UnitedHealth Group's dividend payout ratio (DPR) is 59.72%.
Analyst Ratings Changes
A number of analysts recently issued reports on UNH shares. Leerink Partners raised their price objective on UnitedHealth Group from $400.00 to $462.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 17th. Morgan Stanley increased their price objective on UnitedHealth Group from $468.00 to $529.00 and gave the company an "overweight" rating in a research note on Friday, July 17th. HSBC lifted their price target on shares of UnitedHealth Group from $300.00 to $380.00 and gave the stock a "hold" rating in a research note on Monday, July 6th. Cantor Fitzgerald restated an "overweight" rating on shares of UnitedHealth Group in a report on Thursday, June 11th. Finally, Wells Fargo & Company upped their price target on UnitedHealth Group from $397.00 to $485.00 and gave the company an "overweight" rating in a report on Monday, July 13th. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $456.56.
Read Our Latest Stock Analysis on UnitedHealth Group
Insider Buying and Selling at UnitedHealth Group
In other news, CEO Patrick Hugh Conway sold 1,169 shares of the business's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares of the company's stock, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.19% of the stock is currently owned by company insiders.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
